Rephonic
Artwork for The Uromigos

The Uromigos

The Uromigos
Prostate Cancer
Bladder Cancer
PARP Inhibitors
Renal Cancer
Clinical Trials
Radiotherapy
Pembrolizumab
Metastatic Bladder Cancer
Kidney Cancer
ASCO GU 2024
Combination Therapy
Adjuvant Therapy
PSMA PET Imaging
TALAPRO II
BRCA
Overall Survival
EV302 Study
Hormone Therapy
Salvage Radiotherapy
Androgen Deprivation Therapy

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

PublishesTwice weeklyEpisodes452Founded6 years ago
Number of ListenersCategories
Health & FitnessMedicine

Listen to this Podcast

Artwork for The Uromigos

Latest Episodes

Tom and Brian discuss the bladder cancer highlights from ESMO 2025. Show throwing is discussed.

Silke, Tom and Brian discuss the prostate and RCC highlights from ESMO 2025

Alex Wyatt joins us to discuss Tom's IMvigor011 data and the field of ctDNA

Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
GU Cast | Urology Podcast
GU Cast | Urology PodcastProfessor Declan Murphy & Dr Renu Eapen
The View on GU | with Lalani and Wallis
The View on GU | with Lalani and WallisDr. Aly-Khan Lalani & Dr. Christopher Wallis
OncLive® On Air
OncLive® On AirOncLive® On Air

Recent Guests

Alex Wyatt
Genomic research scientist with 15 years of experience in CT DNA studies
Clinical genomics lab in British Columbia, Canada
Episode: Episode 453: ESMO 2025 - IMvigor011
Matt Galsky
Expert in bladder cancer research
Episode: Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Scott Tagawa
Presenter of the PSMA addition study
Cornell University
Episode: Episode 451: ESMO 2025 - PSMAddition
Elena Castro
Oncologist specializing in prostate cancer therapies
Episode: Episode 450: ESMO 2025 - CAPITELLO
Chris Suarez
Researcher at Valhebron
Valhebron
Episode: Episode 446: ESMO 2025 - OPTIC and front-line RCC triplets
Christian Kollmannsberger
Medical oncologist and researcher in testis cancer treatments
Vancouver, Canada
Episode: Episode 438: The History of Testis Cancer Treatment
Danny Heng
Chair of IMDC from the Arthur Child Cancer Center in Calgary, Alberta, Canada.
Arthur Child Cancer Center
Episode: Episode 434: IMPACT series - A Walk Through the History of VEGF TKI Development in RCC
Axel Bex
A prominent investigator in the field of surgery and drug development in kidney cancer
Episode: Episode 431: IMPACT series - Axel Bex on Impactful RCC Clinical Trials
Kari Cournier
A kinesiology professor at the University of Alberta specializing in behavioral change interventions.
University of Alberta
Episode: Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?

Hosts

Brian Rini
Co-host and Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, with expertise in GU cancer treatments and research.
Tom Powles
Co-host and Director at Barts Cancer Centre, specializing in GU oncology and patient management.

Reviews

4.8 out of 5 stars from 159 ratings
  • Excellent resource for patients anddocs

    The Uromigos keep patients and doctors informed with the very latest studies and research in urogenital cancer. I appreciate their hopeful, upbeat and revealing interviews with cutting edge researchers.

    Apple Podcasts
    5
    Tea Green
    United Statesa month ago
  • Informative podcast

    This podcast is a one-stop shop for all things GU oncology. The information is balanced, up to date and relevant for anyone in this field

    Apple Podcasts
    5
    F93111111
    United Kingdoma year ago
  • Great for staying up on GU oncology

    Drs. Powles and Rini are some of the most eminent current leaders in GU oncology. In this podcast, they discuss recent key studies in the field and really break down the key questions clinicians and patients want to know — are they clinically significant, will they change practice, and what are the next steps? Also, there are a lot of cheesy jokes which this humble listener somehow enjoys.

    Apple Podcasts
    5
    Attentive listener 12345
    United States2 years ago
  • Topical and interesting

    Great discussion of topical issues within the urology space from a engaging, experienced and knowledgeable group of oncologists.

    Apple Podcasts
    5
    Antman1805
    Australia2 years ago
  • Fantastic podcast

    This is a fantastic podcast! Great insight with provocative discussions (while keeping it lighthearted at the same time).... Thank you guys. Keep them coming....

    Apple Podcasts
    5
    Jacky4911
    United States4 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Overall, listeners express a strong appreciation for the depth of knowledge shared by both hosts and guests.
Audience members find the balance of seriousness and humor in discussions refreshing and effective.
Listeners appreciate the insightful discussions on current research and clinical trials in GU oncology.
The hosts are praised for their expertise and ability to make complex topics relatable and engaging.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Episode 454: ESMO 2025 Prostate and Kidney Cancer Review
Q: For which patients would you now use that combination of therapies?
It seems most appropriate for the highest risk patients, although there is still uncertainty about appropriate patient selection.
Episode 454: ESMO 2025 Prostate and Kidney Cancer Review
Q: How much stock should we put in that overall survival result?
While the trial was phase two and smaller in scale, the signal it provides about docetaxel's effectiveness should be valued despite the caveats.
Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Q: How confident are you that DV alone couldn't have beaten chemotherapy by itself?
Matt acknowledges it's a fair question and evaluates the data from phase one and two studies, indicating that the combination shows a benefit.
Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Q: What do you think about the drug before I do the study?
Matt shares insights about Decidum Avidotum, highlighting its development and approval in China for bladder cancer.
Episode 445: ESMO 2025 - Systemic Checkpoint Inhibition plus BCG in NMIBC (POTOMAC and ALBAN)
Q: What advice would you give the urology colleagues about the activity of immune checkpoint inhibition in high-risk muscle invasive bladder cancer?
There are more questions than answers as we look at the data.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Uromigos

What is The Uromigos about and what kind of topics does it cover?

Focusing on the latest advancements in genitourinary (GU) oncology, the content covers a wide range of topics such as prostate and kidney cancers, along with significant clinical trials and treatment innovations. Discussions often revolve around the implications of new research findings, including the effects of various therapies and biomarkers on patient outcomes, as well as historical treatments and their evolution in the medical field. The hosts frequently invite expert guests to enrich these conversations, adding depth to the ongoing dialogue about patient care and emerging therapies in GU cancer. Unique to this series is the blend of expert opinion with light-hearted humor, making complex medical discussions accessible and engaging for... more

Where can I find podcast stats for The Uromigos?

Rephonic provides a wide range of podcast stats for The Uromigos. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Uromigos and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Uromigos get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Uromigos, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Uromigos?

Rephonic provides comprehensive predictive audience data for The Uromigos, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Uromigos have?

To see how many followers or subscribers The Uromigos has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Uromigos?

These podcasts share a similar audience with The Uromigos:

1. Two Onc Docs
2. GU Cast | Urology Podcast
3. The View on GU | with Lalani and Wallis
4. Oncology Brothers: Practice-Changing Cancer Discussions
5. OncLive® On Air

How many episodes of The Uromigos are there?

The Uromigos launched 6 years ago and published 452 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Uromigos?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Uromigos?

Rephonic pulls ratings and reviews for The Uromigos from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Uromigos?

Rephonic provides full transcripts for episodes of The Uromigos. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Uromigos?

Recent guests on The Uromigos include:

1. Alex Wyatt
2. Matt Galsky
3. Scott Tagawa
4. Elena Castro
5. Chris Suarez
6. Christian Kollmannsberger
7. Danny Heng
8. Axel Bex

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days